Invst LLC Invests $888,000 in Intuitive Surgical, Inc. $ISRG

Key Points

• Invst LLC acquired 1,793 shares of Intuitive Surgical, Inc. valued at approximately $888,000, marking a notable addition to their portfolio.
• Over 83% of Intuitive Surgical's stock is owned by institutional investors, highlighting the company's strong appeal among large financial entities.
• Intuitive Surgical exceeded quarterly earnings expectations with $2.19 earnings per share, beating the consensus estimate by $0.26 and posting revenues of $2.44 billion.

Invst LLC purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 1,793 shares of the medical equipment provider's stock, valued at approximately $888,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Modern Wealth Management LLC raised its stake in shares of Intuitive Surgical by 4.5% during the 1st quarter. Modern Wealth Management LLC now owns 1,014 shares of the medical equipment provider's stock valued at $502,000 after buying an additional 44 shares during the last quarter. Silicon Valley Capital Partners grew its holdings in Intuitive Surgical by 7,225.4% during the first quarter. Silicon Valley Capital Partners now owns 18,167 shares of the medical equipment provider's stock worth $8,935,000 after acquiring an additional 17,919 shares during the period. Anderson Financial Strategies LLC purchased a new position in Intuitive Surgical during the first quarter valued at approximately $631,000. Strs Ohio acquired a new position in Intuitive Surgical in the first quarter valued at approximately $41,646,000. Finally, Advisors Capital Management LLC lifted its holdings in Intuitive Surgical by 126.3% in the first quarter. Advisors Capital Management LLC now owns 6,590 shares of the medical equipment provider's stock valued at $3,264,000 after acquiring an additional 3,678 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the stock. Wall Street Zen raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Saturday, July 26th. UBS Group raised their price target on shares of Intuitive Surgical from $547.00 to $585.00 and gave the company a "neutral" rating in a research report on Wednesday, July 23rd. Evercore ISI lifted their price objective on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a report on Tuesday, July 8th. Erste Group Bank reissued a "hold" rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Finally, Piper Sandler restated an "overweight" rating and set a $595.00 target price (up from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Thirteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $595.95.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the sale, the executive vice president owned 353 shares of the company's stock, valued at $173,845.44. The trade was a 92.73% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of the company's stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the sale, the insider directly owned 19,827 shares of the company's stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 45,224 shares of company stock valued at $21,716,492 over the last ninety days. Insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Performance

Shares of ISRG stock traded down $15.69 on Monday, reaching $433.99. 3,471,134 shares of the company were exchanged, compared to its average volume of 2,153,700. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The business has a 50-day moving average price of $483.65 and a 200 day moving average price of $506.85. The company has a market cap of $155.58 billion, a price-to-earnings ratio of 60.53, a P/E/G ratio of 4.71 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. During the same period last year, the company posted $1.78 EPS. Intuitive Surgical's quarterly revenue was up 21.4% compared to the same quarter last year. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.